花旗(C.US)範潔恩據報晤墨西哥總統 談及墨西哥分支Banamex上市
《彭博》引述消息報道,花旗(C.US)行政總裁範潔恩到訪墨西哥首都墨西哥城,與墨西哥總統辛鮑姆會面,談及該行墨西哥分支Banamex的可能公開上市。範潔恩上月在分析師電話會議上表示,該行正按計劃年底前把Banamex上市。
報道指,花旗一直吸引墨西哥富豪購買Banamex大量股份,數量甚至可形成控股權,報道亦提及墨西哥商人Fernando Chico Pardo正尋求在Banamex上市前收購約兩成股份。
花旗2023年取消以70億美元將其墨西哥消費者部門出售給墨西哥富豪German Larrea旗下墨西哥集團的交易,後者當時與時任總統關係緊張導致交易破裂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.